Close Menu

Anaphylaxis

Anaphylaxis to Pegylated Liposomal Doxorubicin: A Case Report

Issue: 
DOI: 
10.7727/wimj.2013.270
Pages: 
376–7
ABSTRACT 
 
Liposomal doxorubicin is used for the treatment of various cancers like epithelial ovarian cancers, multiple myeloma and sarcomas. We report the first case of anaphylaxis to pegylated liposomal doxorubicin.
 
Accepted: 
30 Oct, 2013
PDF Attachment: 
Journal Sections: 
Journal Authors: 
e-Published: 19 May, 2014
Subscribe to RSS - Anaphylaxis
Top of Page